
|Videos|May 26, 2022
Dose Reductions and Treatment Breaks on Lenvatinib Therapy
Author(s)Tom Powles, MBBS, MRCP, MD, Brian Shimkus, MD
Dr Brian Shimkus describes how he doses lenvatinib for renal cell carcinoma treatment.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Current Treatment Landscape of HER2-Positive Metastatic Breast Cancer and Phase 3 Trial Overview
2
The Moonlight Shift: Dr Joshua Richter on Myeloma, Myths, and the C-Word
3
FDA Approves Afami-cel in Metastatic Synovial Sarcoma
4
Zanzalintinib/Atezolizumab Misses Survival End Point in Non-MSI-H mCRC Subgroup
5































































































